X. Mirabel

5.4k total citations · 1 hit paper
167 papers, 3.4k citations indexed

About

X. Mirabel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, X. Mirabel has authored 167 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 66 papers in Surgery and 61 papers in Oncology. Recurrent topics in X. Mirabel's work include Advanced Radiotherapy Techniques (43 papers), Gastric Cancer Management and Outcomes (28 papers) and Esophageal Cancer Research and Treatment (23 papers). X. Mirabel is often cited by papers focused on Advanced Radiotherapy Techniques (43 papers), Gastric Cancer Management and Outcomes (28 papers) and Esophageal Cancer Research and Treatment (23 papers). X. Mirabel collaborates with scholars based in France, Spain and Hungary. X. Mirabel's co-authors include Éric Lartigau, T. Lacornerie, S. Dewas, Antoine Adenis, Jean‐Emmanuel Bibault, Éric François, Jean‐Pierre Gérard, C. Mariette, Thierry Conroy and Bernard Denis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

X. Mirabel

158 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

2010 537 citations V. Vendrely, Éric François et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by X. Mirabel

Since Specialization

Citations

This map shows the geographic impact of X. Mirabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Mirabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Mirabel more than expected).

Fields of papers citing papers by X. Mirabel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Mirabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Mirabel. The network helps show where X. Mirabel may publish in the future.

Co-authorship network of co-authors of X. Mirabel

This figure shows the co-authorship network connecting the top 25 collaborators of X. Mirabel. A scholar is included among the top collaborators of X. Mirabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Mirabel. X. Mirabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma 2024 ·Cancer/Radiothérapie ·(unknown), Małgorzata Roos, (unknown), (unknown), (unknown), Marie‐Cécile Le Deley, (unknown), (unknown), Dominique Pasquier, X. Mirabel, T. Lacornerie, X. Liem	0
2	Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·C. Le Tourneau, Zoltán Takácsi‐Nagy, Laetitia Finzi, X. Liem, Valentin Calugaru, Víctor Moreno, Emiliano Calvo, Sébastien Salas, Bernard Doger, (unknown), X. Mirabel, Nathalie Badois, A. Chillès, Nicolas Fakhry, (unknown), (unknown), (unknown), (unknown), (unknown), Maria Lesnik	1
3	Radiothérapie du cancer du sein en cinq fractions 2023 ·Cancer/Radiothérapie ·(unknown), (unknown), Alexandre Coutté, X. Mirabel, É. Lartigau, Pascale Lemoine, (unknown), Dominique Pasquier	1
4	Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT. 2023 ·Journal of Clinical Oncology ·Antoine Adenis, Guillaume Piessen, Samuel Le Sourd, Emilie Bogart, A. Paumier, V. Vendrely, Olivier Gléhen, Laëtitia Dahan, (unknown), Damien Bergeat, Emmanuelle Samalin, Marion Chauvenet, Xavier Benoît D’Journo, Sandrine Hiret, Caroline Gronnier, (unknown), Diane Pannier, Julie Véziant, Marie‐Cécile Le Deley, X. Mirabel	0
5	Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center 2023 ·Radiotherapy and Oncology ·(unknown), Dominique Pasquier, Emilie Bogart, X. Mirabel, (unknown), (unknown), (unknown), Éric Lartigau, X. Liem	2
6	Comparison of compressed sensing and controlled aliasing in parallel imaging acceleration for 3D magnetic resonance imaging for radiotherapy preparation 2022 ·Physics and Imaging in Radiation Oncology ·F. Crop, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), X. Mirabel	3
7	Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx 2021 ·European Journal of Cancer ·Caroline Hoffmann, Valentin Calugaru, Édith Borcoman, Víctor Moreno, Emiliano Calvo, X. Liem, Sébastien Salas, Bernard Doger, Thomas Jouffroy, X. Mirabel, José Rodriguez, A. Chillès, (unknown), (unknown), Nicolas Fakhry, (unknown), Christophe Le Tourneau	45
8	Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experience 2019 ·International Journal of Radiation OncologyBiologyPhysics ·B. Bataille, (unknown), Alexandre Escande, (unknown), (unknown), Fabrice Narducci, Éric Leblanc, Delphine Hudry, (unknown), Anne Lesoin, (unknown), S. Taïeb, (unknown), Éric Lartigau, X. Mirabel, (unknown)	2
9	Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma 2015 ·British Journal of Dermatology ·(unknown), (unknown), (unknown), X. Mirabel, (unknown), B. Cribier, Laurent Mortier	18
10	Novel Technique for Hepatic Fiducial Marker Placement for Stereotactic Body Radiation Therapy 2014 ·International Journal of Radiation OncologyBiologyPhysics ·H. Jarraya, (unknown), Emmanuelle Tresch, F. Bonodeau, T. Lacornerie, X. Mirabel, Thomas Boulanger, S. Taïeb, Andrew Kramar, Éric Lartigau, L. Ceugnart	14
11	Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy 2012 ·Radiation Oncology ·S. Dewas, Jean‐Emmanuel Bibault, X. Mirabel, I. Fumagalli, Andrew Kramar, H. Jarraya, T. Lacornerie, (unknown), Éric Lartigau	55
12	CT appearance of pulmonary carcinomas after stereotactic radiation therapy 2012 ·Diagnostic and Interventional Imaging ·Jean‐Emmanuel Bibault, L. Ceugnart, B. Prévost, X. Mirabel, Éric Lartigau	14
13	A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases 2012 ·Radiation Oncology ·I. Fumagalli, Jean‐Emmanuel Bibault, S. Dewas, Andrew Kramar, X. Mirabel, B. Prévost, T. Lacornerie, (unknown), Éric Lartigau	38
14	Radiotherapy alone for Merkel cell carcinoma: A comparative and retrospective study of 25 patients 2011 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Nicolas Penel, Julia Salleron, (unknown), P. Guerreschi, (unknown), (unknown), X. Mirabel, Laurent Mortier	47
15	Cancer de l’œsophage 2010 ·Cancer/Radiothérapie ·Olivier Dupuis, G. Ganem, G. Béra, Y. Pointreau, Olivier Pradier, P. Martin, X. Mirabel, Fabrice Denis	5
16	Fréquence des génopathies et des antécédents carcinologiques chez 493 adultes atteints de sarcomes viscéraux ou des tissus mous 2003 ·Bulletin du Cancer ·Nicolas Penel, (unknown), M O Vilain, L. Vanseymortier, L. Ceugnart, S. Taïeb, X. Mirabel, (unknown), (unknown), Marie‐Christine Baranzelli, F. Pichon, (unknown), Y Robin, Éric Lartigau	10
17	Complications cutanées de la radiothérapie (hors tumeurs malignes) 2003 ·Bulletin du Cancer ·(unknown), Éric Delaporte, X. Mirabel, F Piette	9
18	Utilisation d'un système d'imagerie en temps réel dans le contrôle quotidien de patients traités par irradiation pour un cancer thoracique 1997 ·Cancer/Radiothérapie ·G. Noël, (unknown), X. Mirabel, B. Prévost	10
19	Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study 1997 ·Annals of Oncology ·D. Peiffert, Jean‐François Seitz, P. Rougier, Éric François, F. Cvitkovic, X. Mirabel, (unknown), Michel Ducreux, Jean‐Michel Hannoun‐Lévi, A. Lusinchi, (unknown), Thierry Conroy, Jean‐Pierre Pignon, J.P. Gérard	46
20	Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature 1995 ·Radiotherapy and Oncology ·D. Cowen, Pierre Richaud, F. Mornex, Thomas Bachelot, Geena Jung, X. Mirabel, C. Marchal, (unknown), P Rambert, Gilles Chaplain, (unknown), M. Resbeut, (unknown)	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact